
Thursday, November 30, 2023 9:15:12 AM

Recent ITRM News
- Iterum Therapeutics Announces Extension of Term of Promissory Note • GlobeNewswire Inc. • 05/19/2025 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:30:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:15:09 AM
- Iterum Therapeutics Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 • GlobeNewswire Inc. • 05/06/2025 11:00:00 AM
- Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/30/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 01:16:27 AM
- Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/29/2025 12:00:00 PM
- Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics • GlobeNewswire Inc. • 04/14/2025 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 12:35:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2025 05:15:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:49:20 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/07/2025 09:33:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/07/2025 12:30:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 12:15:07 PM
- Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 02/07/2025 12:00:00 PM
- Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 • GlobeNewswire Inc. • 01/31/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 11:30:07 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/10/2024 12:04:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 02:15:44 PM
- Iterum Therapeutics Regains Full Nasdaq Compliance • GlobeNewswire Inc. • 11/21/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 12:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 12:15:08 PM
- Iterum Therapeutics Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/14/2024 12:00:00 PM
Authentic Events, LLC To Broadcast its First Pay Per View with Lingerie Fighting Championships on July 4th 2025 • AHRO • May 22, 2025 8:30 AM
Lingerie Fighting Championships Coming to the UK for July 4 & 6 Events • BOTY • May 19, 2025 10:00 AM
VAYK Projects to Report Over $400K Q1 Revenue • VAYK • May 15, 2025 9:00 AM
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone • VRHI • May 15, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer • BLO • May 14, 2025 8:51 AM
North Bay Resources Announces Resource Estimate of 474,000 ounces at Fran Gold Project, British Columbia • NBRI • May 13, 2025 9:58 AM